Banque Cantonale Vaudoise reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 42.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,588 shares of the biopharmaceutical company’s stock after selling 2,688 shares during the period. Banque […]
Raymond James upgraded shares of Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) from a market perform rating to an outperform rating in a report released on Friday morning, MarketBeat reports. The brokerage currently has $950.00 price objective on the biopharmaceutical company’s stock. Other equities research analysts have also recently issued reports about the company. Morgan Stanley […]
Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) Shares Sold by New York State Common Retirement Fund wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Asio Capital LLC increased its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 1.2% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,270 shares of the biopharmaceutical company’s stock after purchasing an additional 27 shares during the quarter. Asio […]
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its target price lifted by Cantor Fitzgerald from $800.00 to $850.00 in a research report report published on Monday morning, Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. Cantor Fitzgerald also issued estimates for Regeneron Pharmaceuticals’ FY2024 earnings at $34.70 EPS. REGN […]